From October 1, 2022 to December 31, 2022, the company has repurchased 2,012,500 shares, representing 0.17% for CNY 20.85 million. With this, the company has completed the repurchase of 9,771,200 shares, representing 0.82% for CNY 101.9 million under the buyback announced on September 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.21 CNY | +1.84% |
|
+3.89% | -22.97% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.97% | 114.79Cr | |
+55.35% | 85TCr | |
+31.64% | 63TCr | |
-0.10% | 36TCr | |
+15.47% | 32TCr | |
+13.10% | 30TCr | |
+15.51% | 24TCr | |
+16.72% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.